Hepatitis C elimination: challenges with under-diagnosis and under-treatment.
Hepatitis C elimination: challenges with under-diagnosis and under-treatment.
复制标题
DOI：
10.12688/f1000research.15892.1
复制
发表时间：
2019-01-01
期刊：
影响因子：
--
通讯作者：
Terrault, Norah A
中科院分区：
文献类型：
--
作者：
Terrault, Norah A
丙型肝炎感染已影响到全球1.89亿人，美国超过400万人。由于治疗领域的显著进步，基本上可以预期所有受感染的患者都能治愈。这为消除丙型肝炎并发症的风险和减少病毒向他人的传播提供了前所未有的机会。为了实现这一点，可以制定从诊断到治疗的简化级联护理。尽管已经取得了很大进展，但诊断不足和治疗不足仍然是主要障碍。
Hepatitis C infection has affected 189 million people globally and more than 4 million in the US. Owing to remarkable advances in the therapeutic sphere, essentially all infected patients can be expected to achieve cure. This provides an unprecedented opportunity to eliminate the risk of complications from hepatitis C and to reduce the spread of the virus to others. To achieve this, a streamlined cascade of care from diagnosis to treatment may be enacted. Although great strides have been made, under-diagnosis and under-treatment remain major hurdles.